KYNAM CAPITAL MANAGEMENT, LP Celldex Therapeutics, Inc. Transaction History

KYNAM CAPITAL MANAGEMENT, LP portfolio value:

$0
portfolio value

Celldex Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +41.32% 467.86K shares 14.45M $28.11 1.60M
Q3 2022 call Decrease -100.00% -246.4K shares -2.47M $28.11 0
Q2 2022 share Increase +50.36% 379.22K shares 4.87M $26.96 1.13M
Q2 2022 call Increase 0.00% 246.4K shares 2.47M $26.96 246.4K
Q1 2022 share Increase +232.13% 526.30K shares 16.88M $34.06 753.03K
Q4 2021 share Increase 0.00% 226.72K shares 8.76M $38.9 226.72K